CJC-1295 no DAC / Ipamorelin

RT3 (R3TA) is a synthetic 39-amino acid peptide engineered as a triple agonist at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Built on a GIP peptide backbone, it incorporates a C20 fatty diacid moiety that facilitates albumin binding, significantly extending its stability in research models.

Intended for in vitro and in vivo laboratory research only, RT3 is designed for the study of multi-receptor nutrient-stimulated hormone signaling.

Research Applications

• Tri-Receptor Synergies: Investigating the cooperative effects of simultaneous incretin and glucagon receptor activation
• Glucagon Receptor Signaling: Studying the peptide's influence on thermogenesis and energy expenditure pathways via glucagon receptor engagement
• Metabolic Rate Analysis: Researching the impact of multi-incretin mimetics on metabolic homeostasis in animal models
• Pharmacokinetics: Analyzing the role of the C20 fatty acid side chain in extending the half-life and potency of synthetic peptides

Product Details

• Supplied as lyophilized powder
• BAC Water sold separately — syringes not included
• Storage: Keep powder cool and dry; refrigerate after reconstitution

For research purposes only. Not for human consumption.